| Financial Year |
March 31 2023 |
| Monetary Funds |
32,976,828.71 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
40,000.00 |
| Accounts Receivable |
175,238,651.82 |
| Advances to Suppliers |
8,025,786.06 |
| Other Receivables |
19,865,088.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
94,815,119.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,553,329.63 |
| Total Current Assets |
338,514,804.18 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
66,553,834.22 |
| Fixed Assetes |
402,339,580.33 |
| Under-construction Projects |
1,475,254.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
31,577,912.03 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
60,166,082.79 |
| Deferred Income Tax Assets |
37,044,368.16 |
| Other Non-Current Assets |
1,080,000.00 |
| Sub-Total of Non-Current Assets |
600,237,031.67 |
| Total Assets |
938,751,835.85 |
| Short-Term Loans |
195,317,264.10 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
228,172,713.02 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,179,308.26 |
| Taxes Payable |
429,939.26 |
| Interest Payable |
-- |
| Dividend Payable |
122,932.50 |
| Other payables |
211,602,192.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
27,096,268.33 |
| Other Current Liabilities |
1,280,669.05 |
| Sub-Total of Current Liabilities |
687,929,654.93 |
| Long-term Loans |
32,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,945,723.22 |
| Deferred Income Tax Liabilities |
6,130,360.61 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
76,781,210.52 |
| Total Liabilities |
764,710,865.45 |
| Paid-In Capital(Or Share Stock) |
790,108,769.00 |
| Capital Surplus |
756,012,149.27 |
| Surplus Reserve |
27,652,251.51 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,400,363,770.21 |
| Minority Stockholder's Interest |
631,570.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
173,409,399.57 |
| Owner's Equity（Stockholder's Equity） |
174,040,970.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
938,751,835.85 |
